================================================================================

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                    FORM 8-K


                                 CURRENT REPORT


                       Pursuant to Section 13 or 15(d) of
                       The Securities Exchange Act of 1934




          Date of Report (Date of earliest event reported) June 7, 1999




                              AgriBioTech, Inc.

               (Exact name of issuer as specified in its charter)

           Nevada                      0-19352                  85-0325742
 (State or other jurisdiction of     (Commission           (I.R.S. Employer
  incorporation or organization)      File Number)          Identification No.)


              120 Corporate Park Drive, Henderson, Nevada (89014)
               (Address of principal executive offices) (Zip Code)


       Registrant's telephone number, including area code: (702)566-2440

================================================================================

<PAGE>

Item 5. Other Events

     On  June  7,  1999,  AgriBioTech,  Inc.  ("ABT"  or the  "Company")  issued
4,276,850 shares of common stock at  approximately  $6.55 per share totaling $28
million to The State of Wisconsin Investment Board ("SWIB").  As provided in the
Securities  Purchase  Agreement dated as of June 4, 1999, the issuance price was
the average of the  Company's  closing  price per share for the 10 trading  days
from May 21, 1999 through June 4, 1999. The proceeds from the issuance of common
stock to SWIB were used by the  Company to reduce the  outstanding  indebtedness
under its revolving  credit  facility and repay the $10 million  bridge loan the
Company recently  received from Richard Budd, the Company's CEO, and his family.
The Company had used this bridge loan and credit  available  under its revolving
credit  facility  to  redeem,  on  May  28,1999,  its  outstanding  subordinated
convertible  debentures at a price, including accrued interest, of approximately
$27.6 million.

<PAGE>

                                   SIGNATURES

     Pursuant to the  requirement  of the  Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.



                                         AGRIBIOTECH, INC.



Date:  June 9, 1999                      By:  /s/ Randy Ingram
                                              ----------------
                                              Randy Ingram, Co-President and CFO
[{"type": "8-K", "sequence": "1", "description": "FORM 8-K CURRENT REPORT DATED 6/7/99", "secsgml_size_bytes": 2721}]
{"company-data": {"conformed-name": "AGRIBIOTECH INC", "cik": "0000876320", "assigned-sic": "0100", "irs-number": "850325742", "state-of-incorporation": "NV", "fiscal-year-end": "0630"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "333-71477", "film-number": "99643269"}, "business-address": {"street1": "120 CORPORATE PARK DRIVE", "street2": "2700 SUNSET RD STE C- 25", "city": "HENDERSON", "state": "NV", "zip": "89014", "phone": "7025662440"}, "mail-address": {"street1": "120 CORPORATE PARK DRIVE", "city": "HENDERSON", "state": "NV", "zip": "89014"}, "former-company": {"former-conformed-name": "SUSSEX VENTURES LTD", "date-changed": "19930328"}}
================================================================================

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                       Pursuant to Section 13 or 15(d) of
                       The Securities Exchange Act of 1934

          Date of Report (Date of earliest event reported) June 7, 1999

                              AgriBioTech, Inc.

               (Exact name of issuer as specified in its charter)

           Nevada                      0-19352                  85-0325742
 (State or other jurisdiction of     (Commission           (I.R.S. Employer
  incorporation or organization)      File Number)          Identification No.)

              120 Corporate Park Drive, Henderson, Nevada (89014)
               (Address of principal executive offices) (Zip Code)

       Registrant's telephone number, including area code: (702)566-2440

================================================================================
Item 5. Other Events

     On  June  7,  1999,  AgriBioTech,  Inc.  ("ABT"  or the  "Company")  issued
4,276,850 shares of common stock at  approximately  $6.55 per share totaling $28
million to The State of Wisconsin Investment Board ("SWIB").  As provided in the
Securities  Purchase  Agreement dated as of June 4, 1999, the issuance price was
the average of the  Company's  closing  price per share for the 10 trading  days
from May 21, 1999 through June 4, 1999. The proceeds from the issuance of common
stock to SWIB were used by the  Company to reduce the  outstanding  indebtedness
under its revolving  credit  facility and repay the $10 million  bridge loan the
Company recently  received from Richard Budd, the Company's CEO, and his family.
The Company had used this bridge loan and credit  available  under its revolving
credit  facility  to  redeem,  on  May  28,1999,  its  outstanding  subordinated
convertible  debentures at a price, including accrued interest, of approximately
$27.6 million.
SIGNATURES

     Pursuant to the  requirement  of the  Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

                                         AGRIBIOTECH, INC.

Date:  June 9, 1999                      By:  /s/ Randy Ingram
                                              ----------------
                                              Randy Ingram, Co-President and CFO